(4,4-Dimethylcyclohex-1-en-1-yl)boronic acid, 98%, 1g

(2s)-2-{[(9h-fluoren-9-ylmethoxy)carbonyl]amino}-3-(pyrimidin-5-yl)propanoic acid, 98%, 1g

4,4,4-Trifluoro-3-hydroxybutanoic acid, 98%, 5g

GC capillary column ROTI®Cap-1701, 25 m, 0.53 mm, 2.00 µm, 1 Piece(s)

Ethyl 4-(3-bromophenyl)thiazole-2-carboxylate, 95.0%, 5g

N-Methyl-DL-tyrosine hydrochloride, 98.0%, 5g

4-Bromo-7-fluoro-1H-benzo[d]imidazol-2(3H)-one, 97%, 50mg

4-Chloroindoline, 95.0%, 1g

3-Methyl-5-(trifluoromethyl)benzoic acid, 97.0%, 25g

1-(4-Bromo-2-chlorophenyl)ethan-1-amine hydrochloride, 500mg

(S)-2-Methyl-3-phenylpropanoic acid, 100mg

(2-amino-6-methyl-4,5,6,7-tetrahydro-1-benzothien-3-yl)(2,3-dimethoxyphenyl)methanone, 250mg

DL-Homoserine, 95.0%, 10g